European Society of Pathology
Budget
€3,184,050
EP Access
0
accredited persons
Staff
3
2.75 FTE
EU Grants
€21,767
Mission & Goals
As the leading force in European pathology, the European Society of Pathology (ESP) promotes high quality pathology diagnosis for all patients, up-to-date education across Europe and supports cutting-edge research to understand disease and translate science into clinical practice. The Society aims to foster collaboration among pathologists, improve patient diagnostics, and support health policy aligned with EU objectives. ESP represents professionals from academia, clinical laboratories, and research institutions. It actively contributes to EU healthcare and research policy by offering expertise in cancer diagnostics, laboratory medicine, digital pathology, and rare disease identification. ESP engages with EU institutions through: - Participation in scientific consultations and public health initiatives - Expert contributions to policy dialogues on diagnostics, cancer prevention, and education - Organisation of pan-European pathology congresses and training events
EU Legislative Interests
- Public consultations and calls for evidence - Participation in expert panels and health policy workshops - Contribution of position papers on cancer policy, diagnostic quality, and data protection
Communication Activities
ESP engages with EU institutions and agencies in: - Public consultations and calls for evidence - Participation in expert panels and health policy workshops - Contribution of position papers on cancer policy, diagnostic quality, and data protection The Society advocates for high standards in diagnostic accuracy, improved cancer screening, and harmonised pathology training across EU member states.
Interests Represented
Does not represent commercial interests
Member Of
- European Cancer Organisation (ECO) - Biomedical Alliance in Europe - United European Gastroenterology (UEG) - AC Forum - Associations and Conferences Forum - International Collaboration on Cancer Reporting (ICCR) - The International Agency for Research on Cancer (IARC) / WHO
Organisation Members
ESP has individual Members
Additional Information
Additional contributors (ESP Corporate Partners) are: AstraZeneca €85.000, JANSSEN PHARMACEUTICA NV €48.150, GSK €37.500, 3DHISTECH Ltd €55.000, Exact Sciences €25.000
Commissioner Meetings
No recorded meetings with EU commissioners.